Lantern Pharma Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Oct 18-KListing notice or transfer3.01
2. Sep 308-KMaterial agreement and unregistered sale of shares1.013.029.01
3. Sep 30424B5Prospectus for an offering
4. Sep 248-KRegulation FD disclosure7.019.01
5. Sep 238-KRegulation FD disclosure7.019.01
6. Aug 148-KResults of operations and Regulation FD disclosure2.027.019.01
7. Aug 1410-QQuarterly report
8. Aug 413GPassive stake of 5% or more (13G), filed by Empery Asset Management
9. Aug 38-KRegulation FD disclosure7.019.01
10. Jun 12S-1Registration of new shares
11. Jun 18-KRegulation FD disclosure7.019.01
12. May 158-KResults of operations2.029.01
13. May 1510-QQuarterly report
14. May 148-KMaterial agreement and unregistered sale of shares1.013.028.019.01
15. May 14424B5Prospectus for an offering
16. Apr 108-KRegulation FD disclosure7.019.01
17. Mar 30424B5Prospectus for an offering
18. Mar 3010-KAnnual report
19. Mar 308-KResults of operations and Regulation FD disclosure2.027.019.01
20. Jan 238-KRegulation FD disclosure7.019.01
21. Nov 13, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
22. Nov 12, 202510-QQuarterly report
23. Sep 23, 20258-KShareholder vote5.07
24. Aug 13, 20258-KResults of operations2.029.01
25. Aug 13, 202510-QQuarterly report
26. Jul 29, 20258-KOfficer or director change and bylaws or fiscal year changed5.025.039.01
27. Jul 3, 20258-KMaterial agreement1.019.01
28. Jul 3, 2025424B5Prospectus for an offering
29. May 15, 202510-QQuarterly report
30. May 15, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
31. Mar 27, 202510-KAnnual report
32. Mar 27, 20258-KResults of operations and Regulation FD disclosure2.027.019.01
33. Jan 10, 20258-KOfficer or director change5.02
34. Nov 8, 20248-KRegulation FD disclosure7.019.01
35. Nov 7, 202410-QQuarterly report
36. Nov 7, 20248-KResults of operations2.029.01